Entity family

Browse drugs

Named medicines, compounds, vaccines, and pharmacological agents. Examples include metformin, semaglutide, antibiotics.

2articles mentioning drugs

2drug mentions

1distinct drugs extracted

0%of mentions human-reviewed

Active filtersEntity: JAK-inhibitors ×

JAK-inhibitors

This drug is selected. Its supporting articles are shown below.

JAK-inhibitors2

Articles mentioning JAK-inhibitors

2 articles · page 1 of 1

P237 Orofacial granulomatosis in patients with crohn’s disease: clinical characteristics and response to advanced therapies in a large multi-centre cohort

gutjnl · abstract · 2026-06-23 · 1 matching annotations

75.3%

adalimumab risankizumab vedolizumab ustekinumab infliximab JAK-inhibitors orofacial granulomatosis Orofacial granulomatosis (OFG)

…l surgery.Advanced therapies used for treatment of OFG included adalimumab (n=56), infliximab (n=52), ustekinumab (n=23), risankizumab (n=…

P48 Long-term outcomes in children and young people with combined inflammatory bowel disease and hepatobiliary disease: a dual-centre experience

gutjnl · abstract · 2025-10-06 · 1 matching annotations

77.2%

prednisolone Azathioprine mycophenolate mofetil 5-ASA JAK-inhibitors colorectal cancer Primary Sclerosing Cholangitis Autoimmune Sclerosing Cholangitis gallbladder cancer ulcerative colitis+2 more

…patient with IBD-U/PSC. IBD/AIH/AISC subtypes were treated with prednisolone (61.5%), azathioprine (76.9%) or mycophenolate mofetil (15.4%).…